The Prostate

Cover image for Vol. 73 Issue 7

May 2013

Volume 73, Issue 7

Pages 677–787

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. One thousand genomes imputation in the national cancer institute breast and prostate cancer cohort consortium aggressive prostate cancer genome-wide association study (pages 677–689)

      Mitchell J. Machiela, Constance Chen, Liming Liang, W. Ryan Diver, Victoria L. Stevens, Konstantinos K. Tsilidis, Christopher A. Haiman, Stephen J. Chanock, David J. Hunter, Peter Kraft and on behalf of the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

      Version of Record online: 19 DEC 2012 | DOI: 10.1002/pros.22608

    2. Kisspeptin-10 induces dose dependent degeneration in prepubertal rat prostate gland (pages 690–699)

      Faiqah Ramzan, Irfan Zia Qureshi, Muhammad Ramzan, Muhammad Haris Ramzan and Faiza Ramzan

      Version of Record online: 5 NOV 2012 | DOI: 10.1002/pros.22609

    3. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival (pages 700–705)

      Kathryn L. Penney, Haojie Li, Lorelei A. Mucci, Massimo Loda, Howard D. Sesso, Meir J. Stampfer and Jing Ma

      Version of Record online: 5 NOV 2012 | DOI: 10.1002/pros.22611

    4. Negative regulation of NEP expression by hypoxia (pages 706–714)

      Ranjana Mitra, Olivia S. Chao, David M. Nanus and Oscar B. Goodman Jr.

      Version of Record online: 8 NOV 2012 | DOI: 10.1002/pros.22613

    5. Noradrenaline induces binding of Clathrin light chain A to α1-adrenoceptors in the human prostate (pages 715–723)

      Martin Hennenberg, Josef Miersch, Beata Rutz, Frank Strittmatter, Raphaela Waidelich, Christian G. Stief and Dr. Christian Gratzke

      Version of Record online: 4 MAR 2013 | DOI: 10.1002/pros.22614

    6. Growth kinetics of CD133-positive prostate cancer cells (pages 724–733)

      Edwin E. Reyes, Stefan K. Kunovac, Ryan Duggan, Steven Kregel and Donald J. Vander Griend

      Version of Record online: 8 NOV 2012 | DOI: 10.1002/pros.22616

    7. Variation in selenoenzyme genes and prostate cancer risk and survival (pages 734–742)

      Milan S. Geybels, Carolyn M. Hutter, Erika M. Kwon, Elaine A. Ostrander, Rong Fu, Ziding Feng, Janet L. Stanford and Ulrike Peters

      Version of Record online: 9 NOV 2012 | DOI: 10.1002/pros.22617

    8. Identification of transcription factors associated with castration-resistance: Is the serum responsive factor a potential therapeutic target? (pages 743–753)

      Maria Prencipe, Stephen F. Madden, Amanda O'Neill, Gillian O'Hurley, Aedin Culhane, Darran O'Connor, Helmut Klocker, Elaine W. Kay, William M. Gallagher and William R. Watson

      Version of Record online: 28 JAN 2013 | DOI: 10.1002/pros.22618

    9. Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways (pages 754–762)

      Joseph C. Klink, Alok K. Tewari, Elizabeth M. Masko, Jodi Antonelli, Phillip G. Febbo, Pinchas Cohen, Mark W. Dewhirst, Salvatore V. Pizzo and Stephen J. Freedland

      Version of Record online: 28 NOV 2012 | DOI: 10.1002/pros.22619

    10. Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer (pages 763–769)

      Nelma Pértega-Gomes, José R. Vizcaíno, Carlos Gouveia, Carmen Jerónimo, Rui M. Henrique, Carlos Lopes and Dr. Fátima Baltazar

      Version of Record online: 28 NOV 2012 | DOI: 10.1002/pros.22620

    11. Clinical-Pathologic Correlation Between Transperineal Mapping Biopsies of the Prostate and Three-Dimensional Reconstruction of Prostatectomy Specimens (pages 778–787)

      E. David Crawford, Kyle O. Rove, Al B. Barqawi, Paul D. Maroni, Priya N. Werahera, Craig A. Baer, Hari K. Koul, Cory A. Rove, M. Scott Lucia and Francisco G. La Rosa

      Version of Record online: 20 NOV 2012 | DOI: 10.1002/pros.22622